+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Cell Wall Synthesis Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cell Wall Synthesis Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Mycosis Fungoides Therapeutics Market 2021-2025 - Product Thumbnail Image

Mycosis Fungoides Therapeutics Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
Glioma - Competitive Landscape, 2023 - Product Thumbnail Image

Glioma - Competitive Landscape, 2023

  • Report
  • April 2023
  • 450 Pages
  • Global
From
From
From
Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
Keloids Treatment Market Report 2025 - Product Thumbnail Image

Keloids Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Atherosclerosis Therapeutics Market 2024-2028 - Product Thumbnail Image

Atherosclerosis Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 382 Pages
  • Global
From
Barbiturate Drugs - Global Strategic Business Report - Product Thumbnail Image

Barbiturate Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 386 Pages
  • Global
From
Frontotemporal Dementia - Global Strategic Business Report - Product Thumbnail Image

Frontotemporal Dementia - Global Strategic Business Report

  • Report
  • July 2025
  • 381 Pages
  • Global
From
Insomnia Drugs - Global Strategic Business Report - Product Thumbnail Image

Insomnia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 189 Pages
  • Global
From
From
From
Blarcamesine - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine - Global Strategic Business Report

  • Report
  • July 2025
  • 370 Pages
  • Global
From
Levodopa - Global Strategic Business Report - Product Thumbnail Image

Levodopa - Global Strategic Business Report

  • Report
  • July 2025
  • 377 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 276 Pages
  • Global
From
Loading Indicator